Emily M. Leproust, Chief Executive Officer at Twist Bioscience, sold TWST on Oct 5, 2026
Data as of Oct 16
▼ SELL$369K1,840 shares at $200.44Emily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp
- Traded
- Oct 5, 2026
- Disclosed
- Oct 7, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
TWST since disclosure
−14.7%
after the sale
Similar stocks (XLV) since disclosure
+4.7%
XLV — its sector index fund
Change in closing price from Oct 7, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLEmily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp$96.8Kdisclosed Oct 7 · filed 2 days after the trade
- ▼ SELLEmily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp$9.3Kdisclosed Oct 7 · filed 2 days after the trade
- ▼ SELLEmily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp$206Kdisclosed Oct 7 · filed 2 days after the trade
- ▼ SELLEmily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp$30.2Kdisclosed Oct 7 · filed 2 days after the trade
- ▼ SELLEmily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp$61.1Kdisclosed Oct 7 · filed 2 days after the trade
- ▼ SELLEmily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp$88Kdisclosed Oct 7 · filed 2 days after the trade
- ▼ SELLEmily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp$59.4Kdisclosed Oct 7 · filed 2 days after the trade